TerminatedNot applicableNCT01992068

Pilot Study: Utilizing Manometry to Assess Radiation-Induced Changes in Esophageal Function

The purpose of this study is to prospectively assess the feasibility of high-resolution manometry to identify radiation-induced changes in esophageal motility and contractility or "function" in patients undergoing radiation therapy for the treatment of locally advanced lung cancer.

Checked against the public recordLast updated Apr 6, 2017 · Source: ClinicalTrials.gov

StatusTerminated
PhaseNot applicable
U.S. locations1
SponsorUNC Lineberger Comprehensive Cancer Center
01
Study overview

What this study is about

Purpose
Not specified
Study type
Observational
Phase
Not applicable
Sponsor
UNC Lineberger Comprehensive Cancer Center
Interventions being studied
Not specified
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

Disease setting
Treatment approach
03
Public criteria

Who may be able to participate

Inclusion Criteria: * Age ≥ 18 years or older * Absence of any severe disorders of esophageal motility (patients with reflux and/or a hiatal hernia are eligible) * Histologically confirmed lung cancer scheduled to undergo conventionally fractionated radiation treatment * Patients that will be treated with a minimum of 45 Gy of radiation therapy * Patients with mediastinal nodal disease, or primary lesions that are near the esophagus are eligible provided that they are not having esophageal symptoms believed to be due to the tumor. Exclusion Criteria: * History of esophageal motility disorder that pre-dates and is unrelated to the present diagnosis of lung cancer * History of any prior radiotherapy to the esophagus * Pregnant or lactating women * Inability to understand and follow swallowing instructions for the esophageal manometry procedure; this is to ensure patient compliance of performing the breath hold technique throughout the radiation therapy treatment * Patients with mediastinal nodal disease, or primary lesions, that are having esophageal symptoms believed to be due to the tumor

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • Department of Radiation Oncology ClinicChapel Hill, North Carolina

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Apr 6, 2017. Always confirm current availability with the study team.

View original record ↗